The endorsement means the EMA will offer Carthera support and advice as it moves towards a regulatory filing for its ...

Following positive opinion, Carthera is one of the first companies to benefit from brand-new status – intended to support early access pathways for innovative devices targeting rare diseasesParis, ...

Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for ...

Production on season two of the prequel series begins today in Scotland. The post Outlander: Blood of my Blood Renewed Ahead ...

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...

According to data from SOS Children’s Villages and the World Population Review, Nigeria has an estimated 17.5 to 18 million orphaned children, ranking it among the top five countries globally ...

NH HEALTH This 87-year-old is donating blood in all 50 states “I’m doing it again,” Al Whitney said on Wednesday, when he made New Hampshire his 29th stop ...

About Hereditary Hemorrhagic Telangiectasia (HHT) ‍HHT is a rare disease that affects more than 150,000 people in the U.S. and EU, and for which there are currently no approved therapies. In HHT, loss ...

Sometimes a sought-after spinoff just can't live up to the legacy of its predecessor. Orphan Black: Echoes, which aired in 2024, might just be one of the most disappointing TV series of all time.

The FDA has granted orphan drug designation (ODD) to SENTI-202 for relapsed/refractory (R/R) hematologic malignancies, including acute myeloid leukemia (AML). SENTI-202 is a first-in-class, ...